HealthyWay Inc., an investment holding company, provides corporate and digital marketing, and health and medical services in the People’s Republic of China. The...
HealthyWay opened lower and fell throughout the session, closing down 0.84% at HKD 2.40, with a daily low of HKD 2.40, a maximum decline of about 2.4%, and total turnover of HKD 23.476 million. The company recently revised its IPO proceeds allocation to prioritize AI and healthcare ecosystem growth, and reported a full-year 2025 net profit of RMB 55.68 million, turning around from a loss. Q4 revenue reached HKD 581 million, up 85.3% YoY, with net profit of HKD 27.03 million, up 123.9% YoY, and a net profit margin of 4.65%. However, the stock remains under pressure, down 47.6% YTD, 89.7% below its 52-week high of HKD 23.30, and trading below both its 20-day MA (HKD 2.736) and 60-day MA (HKD 3.693), reflecting ongoing market digestion of growth expectations.
HK Micro-Caps on the Move: AI Monetization to Asset Management Overhauls
HealthyWay schedules board meeting to review interim results, weigh dividend
Jiankang Zhilu surges 14% in Hong Kong on AI push and profitability
Hong Kong Micro-Caps Diverge as Robotics Gain and Biotech Falters
The Hong Kong Grab Bag: Kingboard's AI Hardware Push and Yidu Tech's New Agents
HK Mid-Caps Show Divergent Trajectories as Biotech Advances While Retail Faces Headwinds